'I'm in control of my sexual health' - UK gonorrhoea vaccine rollout begins
The jabs will first be offered to those at highest risk - mostly gay and bisexual men who have a history of multiple sexual partners or sexually transmitted infections.
NHS England say the roll out is a world-first, and predict it could prevent as many as 100,000 cases, potentially saving the NHS almost £8m over the next decade.
The Terrence Higgins Trust, who campaigned for the vaccine to be introduced in the UK, told the BBC it was "a huge win" for sexual health.
Gonorrhoea is a bacterial infection that is transmitted through unprotected sex.
Symptoms can include pain, unusual discharge, inflammation of the genitals and infertility, but in some cases it can have no symptoms at all.
The NHS says it can be avoided by the proper use of condoms and by accepting the vaccine if offered.
Doctors are becoming increasingly worried about the number of infections, and hope the vaccine, which is 30-40% effective, will also help slow the growing number of antibiotic-resistant cases.
The vaccine, known as the 4CMenB vaccine, was designed for preventing meningitis B in babies, but the bacteria that causes the two diseases are so closely related that the jab is also effective against gonorrhoea.
There were more than 85,000 cases of gonorrhoea in 2023 - the highest since records began almost 100 years ago.
One of those diagnosed was Joey Knock, who says the infection gave him diarrhoea, made him feel "wiped out" and led to him taking time off work to recover.
He told BBC News: "I discussed it with my friends and I definitely had worse symptoms [than them] with it.
"I felt really bad, I couldn't keep food down and I just felt totally run down."
Because he has many sexual partners, the 35-year-old decided to pay a private pharmacy for a course of gonorrhoea vaccinations in February 2024 before travelling abroad to a festival.
He paid £220 and says he's glad he did it.
"It helps knowing that I'm taking control of my sexual health and doing what I can to stay safe and practise safer sex and be much less worried about the severity of the symptoms," he says.
Joey says he uses the protection the vaccine offers him alongside other methods of safer sex, including taking PrEP, a drug which helps prevent HIV, and DoxyPep - antibiotics taken after sex to prevent bacterial STIs, a treatment not widely available on the NHS.
He says he also occasionally uses condoms - but sees the vaccine as an extra tool to keep him safe in situations where he or his partner doesn't want to use them.
Since being vaccinated, Joey has been re-infected with gonorrhoea but says the symptoms were much less severe.
He told the BBC: "I've been able to get on with my day and it has just become something much more manageable, and getting tested regularly and knowing my body really helps too."
Matthew, a 63-year-old from East Scotland, was diagnosed with gonorrhoea 10 years ago and had a reaction known as reactive arthritis - extreme pain in your joints caused by your body's reaction to an infection.
He told the BBC that the experience, which has caused lasting damage to some of his fingers and toes, was so painful it's left him fearful of becoming re-infected and has impacted his mental health.
He says: "I'm constantly looking for symptoms and I'm constantly aware of it, and I feel a bit like I used to do in the 1980s when I was constantly fretting about HIV.
"I'd get some sort of cough and think 'oh my god, what's happening?'"
He is hoping to be one of the first people to get a vaccine in order to give himself and his sexual partners more protection.
"You're not just protecting yourself, you're protecting your partners.
"I think it will also relieve some of the burden on sexual health services, it's getting difficult to get appointments so if it can work to reduce the incidence of STIs I think it's really worth it."
Richard Angell, chief executive of the Terrence Higgins Trust, a leading sexual health charity, told the BBC the vaccine was a "remarkable addition to our toolkit on sexual health".
Dr Amanda Doyle, NHS national director for primary care and community services, said it was important "everyone eligible takes up the offer through sexual health services" in order to "keep each other safe".
"It's a real step forward for sexual health," she added.
People who may be eligible for the vaccine are being asked to contact their local sexual health clinic for more information.
Pride in London returns as events struggle with falling funds
'I had a criminal record for 56 years for being a lesbian - nobody told me'
'Our love is frowned upon, but we push through': Navigating religion and relationships
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
22 minutes ago
- Washington Post
RFK Jr.'s slander of mRNA technology will harm Americans
Robert F. Kennedy Jr.'s decision to cancel almost $500 million in contracts for projects to develop vaccines using mRNA technology underscores perhaps the greatest harm that he might inflict on the nation with his anti-vaccine ideology. The disparagement of existing immunizations by the health and human services secretary is dangerous on its own, in that it might persuade people to forego recommended shots and reduce herd immunity against diseases. But potentially even worse are the impacts that will be harder to see: the diseases that public health officials won't be able to fight because of the lifesaving innovations he is cutting short. Kennedy's resistance against mRNA vaccines is without evidence. In fact, the technology — which instructs the body's cells to produce a harmless bit of virus that is then used to train the immune system, as opposed to using weakened or dead versions of a virus — delivered arguably the most important achievement of President Donald Trump's first term: the production of effective vaccines against the novel coronavirus within the span of a few months. Such speed was practically unheard-of in biomedical research. Thanks to the urgency created by Operation Warp Speed, the federal government was able to mount an impressive vaccination rollout that boosted the population's immunity to the coronavirus just when it was needed. As with any medical treatment, these vaccines were not perfect. In very rare instances among adolescents, they resulted in a serious side effect known as myocarditis, or inflammation of the heart muscle. Their effectiveness also waned over time as the coronavirus mutated, as is the case with vaccines for other respiratory diseases. But there can be no doubt: These vaccines saved millions of lives. Kennedy absurdly claimed in a video statement that 'mRNA vaccines don't perform well against viruses that infect the upper respiratory tract.' He further claimed that a single mutation in a virus can render vaccines 'ineffective.' He even went so far as to argue that this effect 'encourages' mutations and could 'prolong' a pandemic. This is just plain wrong, as the covid pandemic demonstrated. The effectiveness of mRNA coronavirus vaccines might have diminished over time, but they continued to protect people against severe illness over the course of multiple strains. In fact, the Centers for Disease Control and Prevention continued to recommend the shots for vulnerable populations for that reason, and manufacturers updated boosters to combat new strains. Giving up on this game-changing technology will slow down scientific innovation, leaving Americans more vulnerable to diseases. Kennedy just canceled or altered 22 mRNA projects that were supported by the Biomedical Advanced Research and Development Authority. On the chopping block are vaccine developments for several respiratory illnesses. That includes a project to defend the country against the H5N1 bird flu virus, which scientists warn could spiral into a deadly pandemic if someone contracts it while also infected with the seasonal flu virus. And that's just the beginning. Researchers are eager to deploy mRNA technology against a slew of other hard-to-tackle pathogens, from hepatitis C to HIV to malaria. There are even efforts to use this approach to activate the immune system to attack cancer cells and to treat other genetic diseases. Some scientists have suggested this research could also be essential for national security, as it might help defend against attacks from biological weapons. Calling Kennedy's latest actions shortsighted understates the gravity of his slander. Americans will bear the cost of his rejection of science.
Yahoo
an hour ago
- Yahoo
Glasgow hospice funding plea as it reveals £755k shortfall
A GLASGOW hospice has begun a fundraising campaign after revealing it faces a shortfall of more than three quarters of a million pounds. The Prince and Princess of Wales Hospice in Bellahouston Park is hoping 'the local community' will support its Vital Care Appeal. Chief Executive Rhona Baillie said: 'We provide free specialist palliative and end-of-life care to 1200 new patients and their families each year, both at the hospice at Bellahouston Park and in patients' own homes. 'We're doing everything we can to keep our costs to a minimum. We run our services efficiently, we're innovating with our fundraising, and we make every pound count. 'But despite our efforts, a significant funding gap remains.' (Image: Colin Mearns/Newsquest) The hospice is predicting a £755,000 shortfall in funding, citing the rise in demand for its services, patients' more complex needs and rising costs as the main pressures. Ms Baillie said that 'with local government funding just 30 per cent of running the hospice, the remaining 70 per cent comes from fundraising and donations' and added: 'We're not in crisis yet, but we need to act and that's why we are turning to our friends in the community for help.' Kirsty with her dad, Robert (Image: PPWH) Kirsty Dolan, 22, is supporting the appeal following the death of her dad, Robert, in the hospice in 2021. Robert was diagnosed with Parkinson's when he was 48 and Kirsty, who was only 10 at the time, along with her mum and older sister, became carers for him. In 2021, he visited the hospital for inpatient care. READ NEXT: Seeds of trees which survived Hiroshima help create new Glasgow garden Glasgow pupil heading for top art school after exam success 'We'll use King's Honours to keep battling for our Glasgow community' 'He had developed supranuclear palsy and needed specialist care,' said Kirsty. 'He was in the IPU for about a week where he just received the very best care you could imagine. 'We got to spend as much time with him as we could, and we even got to bring our dogs in for a visit. When he was nearing the end of his life, we all stayed over at the hospice in the family rooms so we could be close.' Kirsty also received support from the hospice's Family Support Service. 'I was really struggling,' she said. 'I was at breaking point. I emailed the hospice and the Family Support Service got in touch – and I have to say, it changed my life. "The team worked with me over a period of time and just helped me see things differently. ' It really was a lifeline, and I needed that support so much.' Glasgow Times readers helped raise the £21m needed for the new hospice, which opened in 2018, through our Brick by Brick Appeal. For more information on the Vital Care Appeal visit or call 0141 726 2660.
Yahoo
2 hours ago
- Yahoo
RFK Jr. is canceling mRNA vaccine development. Can I still get a COVID vaccine?
Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks than benefits. In a video posted on X Aug. 5, Kennedy said the decision will impact 22 projects worth nearly $500 million at the Biomedical Advanced Research and Development Authority, which helps companies develop medical supplies to address public health threats. Messenger RNA, or mRNA, is used in the two most common COVID-19 vaccines licensed in the U.S. Kennedy's announcement has raised questions about these vaccines, how mRNA works and what this decision means for future research. "This technology played a vital role in our pandemic response and continues to show promise for treating serious diseases," said Jeff Coller, Bloomberg Distinguished Professor of RNA biology and therapeutics at Johns Hopkins University. "As other countries advance these proven, safe and effective therapies, American patients may increasingly depend on foreign innovation for breakthrough treatments." How do mRNA vaccines work? The COVID-19 vaccine works by instructing the body's immune system to recognize the virus and creating fighting antibodies to attack it. Messenger RNA, or mRNA, is a code that tells the body's cells to produce just a piece of the virus, the protein on the surface. The code is protected by a lipid coating, like a fat bubble. mRNA vaccines: RFK Jr. to wind down $500M vaccine development Once injected into the body, the vaccine releases the mRNA to program the cell to produce the spike proteins like those on the surface of SARS-CoV-2, the COVID-19 virus. Our immune system recognizes those vaccine-created spike proteins as invaders and creates antibodies to block future attacks from the virus. Messenger RNA vaccines contain only a fraction of the virus, so unlike some vaccines, they can't give people the disease they're trying to prevent or trigger allergies to eggs or other traditional vaccine ingredients. Should I expect a COVID vaccine this fall? It's unclear whether patients should be expecting COVID-19 vaccines this fall, said Dr. Beth Oller, a family physician in Stockton, Kansas, and clinical instructor at the University of Kansas School of Medicine-Wichita. In June, Kennedy fired all members of the Advisory Committee on Immunization Practices, a key vaccine panel that makes recommendations for COVID-19 and other vaccines, and appointed eight new members. During its first meeting, the committee did not make any recommendations for the fall and isn't expected to reconvene until "September/October," according to the Centers for Disease Control and Prevention website. Kennedy said on May 27 that the COVID-19 vaccine would no longer be included in the CDC's recommended immunization schedule for healthy children and pregnant women, a move that broke with previous expert guidance and bypassed the normal scientific review process. Under the changes, the only people who will be recommended for COVID-19 vaccines are those over 65 and people with existing health problems. This could make it harder for others who want the COVID-19 vaccine to get it, including health care workers and healthy people under 65 with a vulnerable family member or those who want to reduce their short-term risk of infection. The American College of Obstetricians and Gynecologists (ACOG) and American Academy of Pediatrics (AAP), among other organizations, issued statements condemning the change, with the ACOG saying it was "...concerned about and extremely disappointed by the announcement that HHS will no longer recommend COVID-19 vaccination during pregnancy." Will insurance cover my COVID shot? Many consumers are worried about possible cuts to health insurers' coverage of vaccines, a recent poll said. A KFF poll published Aug. 1 found 40% of adults said they will "definitely" or "probably" get a COVID-19 vaccine shot. Of those who intend to get vaccinated, 62% said they are worried insurance won't cover the cost of the vaccine. Groups representing commercial health insurance companies said they still plan to cover vaccines recommended by the CDC and ACIP, the vaccine advisory panel. "Health plans continue to follow federal requirements related to coverage of ACIP-recommended vaccines and will continue to support broad access to critical preventive services, including immunizations," said Tina Stow, spokesperson for AHIP, which represents health insurance companies. COVID: As new variant spreads, what's the latest vaccine guidance? The CDC currently recommends shared decision-making between parents and doctors for immunizing children with the COVID-19 vaccine. It also recommends vaccines for people who are moderately or severely immune compromised. Large employers that provide health insurance benefits for workers and their families will likely continue to cover Food and Drug Administration-approved vaccines, said James Gelfand, president and CEO of the ERISA Industry Committee. In some cases, employer vaccine coverage might follow FDA approvals rather than narrower ACIP Mary Walrath-Holdridge Adrianna Rodriguez can be reached at adrodriguez@ This article originally appeared on USA TODAY: RFK Jr. defunds COVID shot technology. What is mRNA vaccine? Solve the daily Crossword
